STOCK TITAN

Avant Brands Expands Global Footprint with BLK MKT(TM) Launch in Australia

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

Avant Brands Inc. has entered an exclusive trademark licensing agreement with Nectar Portfolio Pty to introduce its BLK MKT™ brand to the Australian medical cannabis market. This expands Avant's global footprint, with BLK MKT™ now available in Canada, Australia, Germany, Israel, and Switzerland, reaching a combined population of about 127 million.

Key highlights include:

  • Nectar's exclusive rights to market, sell, and distribute BLK MKT™ dried cannabis flower in Australia for two years
  • Products will be cultivated by Avant in Canada, meeting Australian medicinal cannabis standards
  • Avant will receive its standard international sales price plus a royalty fee on Nectar's net sales

This partnership is expected to generate incremental revenue growth for Avant Brands and establish BLK MKT™ as a leading global cannabis brand.

Avant Brands Inc. ha stipulato un accordo di licenza per marchio esclusivo con Nectar Portfolio Pty per introdurre il suo marchio BLK MKT™ nel mercato australiano della cannabis medica. Ciò espande la presenza globale di Avant, con BLK MKT™ ora disponibile in Canada, Australia, Germania, Israele e Svizzera, raggiungendo una popolazione complessiva di circa 127 milioni.

I principali punti salienti includono:

  • I diritti esclusivi di Nectar per commercializzare, vendere e distribuire il fiore di cannabis essiccato BLK MKT™ in Australia per due anni
  • I prodotti saranno coltivati da Avant in Canada, conformi agli standard australiani per la cannabis medica
  • Avant riceverà il suo prezzo di vendita internazionale standard più una commissione sulle vendite nette di Nectar

Questa partnership dovrebbe generare una crescita del fatturato per Avant Brands e stabilire BLK MKT™ come un marchio leader nella cannabis a livello globale.

Avant Brands Inc. ha firmado un acuerdo de licencia de marca exclusiva con Nectar Portfolio Pty para introducir su marca BLK MKT™ en el mercado australiano de cannabis medicinal. Esto amplía la huella global de Avant, con BLK MKT™ ahora disponible en Canadá, Australia, Alemania, Israel y Suiza, alcanzando una población combinada de aproximadamente 127 millones.

Los puntos destacados incluyen:

  • Los derechos exclusivos de Nectar para comercializar, vender y distribuir la flor de cannabis seca BLK MKT™ en Australia durante dos años
  • Los productos serán cultivados por Avant en Canadá, cumpliendo con los estándares australianos de cannabis medicinal
  • Avant recibirá su precio de venta internacional estándar más una tarifa de regalías sobre las ventas netas de Nectar

Se espera que esta asociación genere un crecimiento adicional en los ingresos para Avant Brands y establezca a BLK MKT™ como una marca de cannabis líder a nivel global.

Avant Brands Inc.가 Nectar Portfolio Pty와 독점 상표 라이선스 계약을 체결하여 BLK MKT™ 브랜드호주 의약용 대마초 시장에 소개합니다. 이는 Avant의 글로벌 입지를 확장하며, BLK MKT™는 이제 캐나다, 호주, 독일, 이스라엘, 스위스에서 제공되어 약 1억 2700만 명의 인구에 도달합니다.

주요 하이라이트는 다음과 같습니다:

  • Nectar가 호주에서 BLK MKT™ 건조 대마초 꽃을 마케팅, 판매 및 배포할 수 있는 독점 권리 2년 보유
  • 제품은 Avant가 캐나다에서 재배하며 호주 의약용 대마초 기준을 충족함
  • Avant는 표준 국제 판매 가격을 받고 Nectar의 순 판매에 대한 로열티 수수료를 받음

이번 파트너십은 Avant Brands에 추가적인 수익 성장을 가져오고 BLK MKT™를 글로벌 대마초 브랜드로 자리 잡을 것으로 예상됩니다.

Avant Brands Inc. a conclu un accord de licence de marque exclusif avec Nectar Portfolio Pty pour introduire sa marque BLK MKT™ sur le marché australien du cannabis médical. Cela étend l'empreinte mondiale d'Avant, BLK MKT™ étant désormais disponible en Canada, Australie, Allemagne, Israël et Suisse, atteignant une population combinée d'environ 127 millions.

Les points clés incluent :

  • Les droits exclusifs de Nectar pour commercialiser, vendre et distribuer la fleur de cannabis séchée BLK MKT™ en Australie pendant deux ans
  • Les produits seront cultivés par Avant au Canada, conformément aux normes australiennes sur le cannabis médicinal
  • Avant recevra son prix de vente international standard ainsi qu'une redevance sur les ventes nettes de Nectar

Ce partenariat devrait générer une croissance de revenus supplémentaire pour Avant Brands et établir BLK MKT™ comme une marque de cannabis leader à l'échelle mondiale.

Avant Brands Inc. hat einen exklusiven Lizenzvertrag für Markenrechte mit Nectar Portfolio Pty abgeschlossen, um seine BLK MKT™-Marke auf dem australischen Markt für medizinisches Cannabis einzuführen. Dies erweitert die globale Präsenz von Avant, da BLK MKT™ nun in Kanada, Australien, Deutschland, Israel und der Schweiz verfügbar ist und damit eine Gesamtbevölkerung von etwa 127 Millionen erreicht.

Wichtige Highlights sind:

  • Nectars exklusive Rechte zur Vermarktung, zum Verkauf und zur Verteilung von BLK MKT™ getrockneten Cannabisblüten in Australien für zwei Jahre
  • Die Produkte werden von Avant in Kanada kultiviert und entsprechen den australischen Standards für medizinisches Cannabis
  • Avant erhält seinen standardmäßigen internationalen Verkaufspreis plus eine Lizenzgebühr auf Nectars Nettoumsatz

Diese Partnerschaft wird voraussichtlich zu einem zusätzlichen Umsatzwachstum für Avant Brands führen und BLK MKT™ als führende globale Cannabismarke etablieren.

Positive
  • Expansion into the Australian medical cannabis market through exclusive partnership with Nectar
  • Increased global footprint with BLK MKT™ now available in 5 countries
  • Potential for additional revenue through standard international sales price and royalty fee structure
  • Maintenance of product quality and brand reputation through cultivation at Avant's Canadian facilities
Negative
  • None.

KELOWNA, BC and MELBOURNE, AUSTRALIA / ACCESSWIRE / September 23, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading Canadian producer of award-winning, craft cannabis products, today announced that it has entered into an exclusive trademark licensing agreement with Nectar Portfolio Pty Ltd. ("Nectar"), a leading Australian medicinal cannabis importer and distributor. This landmark agreement marks Avant's strategic entry into the rapidly growing Australian medical cannabis market, introducing its renowned BLK MKT™ brand to a new audience.

The agreement with Nectar adds to Avant Brands' growing international presence, with the BLK MKT™ brand now available in Canada, Australia, Germany, Israel, and Switzerland, representing a combined population of approximately 127 million. The Company is actively engaged in discussions to further expand the reach of its premium cannabis brands into additional global markets. It is anticipated that BLK MKT™ products will be available to Australian consumers in the coming months.

Key Highlights:

  • Exclusive Partnership: Nectar gains exclusive rights to market, sell, and distribute BLK MKT™ dried cannabis flower throughout Australia for a two-year term, with the potential for extension based on performance.

  • Premium Brand Recognition: The BLK MKT™ brand is synonymous with ultra-premium quality and a commitment to craft cultivation practices, offering a unique and sought-after experience for consumers. BLK MKT™ stands out in the market due to its unparalleled craft cultivation and ultra-premium cannabis offering.

  • Authentic Canadian Cannabis: BLK MKT™ products in Australia will be cultivated exclusively by Avant at its Licensed Facilities in Canada, featuring the same high-quality cultivars that have established the brand's reputation in Canada. All products will be grown to meet Australian medicinal cannabis standards, ensuring compliance with local regulations.

  • Global Expansion: This partnership expands Avant's global footprint, with BLK MKT™ now available in Australia, Germany, Israel, and Switzerland, and active discussions underway for further international expansion.

  • Stringent Quality Control: All BLK MKT™ products sold internationally will adhere to Avant's rigorous quality control standards, ensuring the brand's reputation for excellence is maintained.

  • Royalty Structure: Avant will receive its standard international sales price for BLK MKT™ products. Additionally, Avant will earn an additional royalty fee on Nectar's net sales of these products, ensuring a steady revenue stream from this strategic partnership.

Norton Singhavon, Avant Brands Founder and CEO commented:

"We are excited to partner with Nectar Brands, a leader in the Australian medical cannabis industry, to bring our flagship BLK MKT™ brand to patients in Australia. This agreement represents a significant step in our global expansion strategy and we anticipate that it will generate incremental revenue growth for Avant Brands. We believe that the Australian market, as well as other key international markets, presents a tremendous opportunity for growth, and we are confident that our partnerships will be instrumental in establishing BLK MKT™ as a leading global cannabis brand."

Chris Nasr, CEO of Nectar, added:

"We are excited to collaborate with Avant Brands and introduce BLK MKT™ to Australian patients. We are committed to delivering the same exceptional quality and experience that BLK MKT™ is known for in Canada, ensuring that Australian patients have access to the best possible cannabis products."

About Nectar Brands Pty Ltd

Nectar Brands Pty Ltd is a house of healthcare brands at the forefront of Australia's digital health and medicinal cannabis sectors, focused on delivering innovative healthcare solutions and ensuring access to high-quality medicines. Nectars' subsidiary is a leading importer and distributor of medicinal cannabis products in Australia. Committed to improving the lives of Australian patients, Nectar provides safe and effective cannabis-based therapies, fostering better health outcomes and advancing the medical cannabis landscape.

About Avant Brands Inc.

Avant is an innovative, market-leading premium cannabis company. Avant has multiple operational production facilities across Canada, which produce high-quality, handcrafted cannabis products based on unique and exceptional cultivars.

Avant offers a comprehensive product portfolio catering to recreational, medical, and export markets. Avant's consumer brands, including BLK MKT™, Tenzo™, Cognōscente™, flowr™ and Treehugger™, are available in key recreational markets across Canada. Avant's products are distributed globally to Australia, Israel and Germany, with its flagship brand BLK MKT™ currently being sold in Israel. Additionally, Avant's medical cannabis brand, GreenTec™, serves qualified patients nationwide through its GreenTec Medical portal and trusted medical cannabis partners.

Avant is a publicly traded corporation listed on the TSX (TSX:AVNT) and accessible to international investors through the OTCQX Best Market (OTCQX:AVTBF) and Frankfurt Stock Exchange (FRA: 1BU0). Headquartered in Kelowna, British Columbia, Avant operates in strategic locations including British Columbia, Alberta, and Ontario.

For more information about Avant, including access to investor presentations and details about its consumer brands, please visit www.avantbrands.ca.

For further inquiries, please contact:
Investor Relations at Avant Brands Inc.
1-800-351-6358
ir@avantbrands.ca

Cautionary Statement Regarding Forward-Looking Information

This press release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws (collectively, "forward-looking statements"). All statements, other than statements of historical fact, included herein are forward-looking statements. In particular, forward-looking statements in this press release include, but are not limited to, statements regarding the expected benefits of the exclusive trademark licensing agreement with Nectar Portfolio Pty Ltd., the potential for Avant Brands Inc. ("Avant") to expand into new international markets, the anticipated growth and opportunities in the Australian medical cannabis market, the expected quality and market reception of BLK MKT™ products in Australia and other global markets, and the expectation of a steady revenue stream from the strategic partnership with Nectar.This includes the impact of upcoming regulatory changes in emerging international markets.

Forward-looking statements are typically identified by words such as "believes," "expects," "anticipates," "intends," "estimates," "plans," "may," "will," "would," "could," "should," "continues," "potential," "opportunity," and similar expressions. These forward-looking statements reflect Avant's current beliefs and are based on information currently available to Avant and assumptions it believes are reasonable. However, these forward-looking statements are subject to numerous risks, uncertainties, and other factors, many of which are outside of Avant's control, that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. This includes the impact of upcoming regulatory changes in emerging international markets.

These risks and uncertainties include, but are not limited to: the ability of Avant to successfully integrate and achieve the anticipated benefits of the licensing agreement with Nectar Portfolio Pty Ltd.; the successful cultivation and quality control of BLK MKT™ products; the acceptance of BLK MKT™ products by the Australian market and other international markets; the realization of anticipated revenue from the strategic partnership; regulatory changes and developments affecting Avant's operations and products; competition within the cannabis industry; economic and market conditions; and other risk factors set forth in Avant's public filings with Canadian securities regulators on SEDAR+ at www.sedarplus.ca.

Readers are cautioned not to place undue reliance on forward-looking statements. Avant does not undertake any obligation to update any forward-looking statements, except as required by applicable law. All forward-looking statements contained in this press release are expressly qualified by this cautionary statement. This includes the impact of upcoming regulatory changes in emerging international markets.

SOURCE: Avant Brands Inc.



View the original press release on accesswire.com

FAQ

What is the significance of Avant Brands' partnership with Nectar for the Australian market?

The partnership allows Avant Brands to introduce its BLK MKT™ brand to the Australian medical cannabis market, expanding its global footprint and potentially generating incremental revenue growth.

How long is the initial term of the exclusive trademark licensing agreement between Avant Brands and Nectar?

The initial term of the exclusive trademark licensing agreement is for two years, with the potential for extension based on performance.

In which countries is Avant Brands' BLK MKT™ brand now available after this expansion?

After this expansion, the BLK MKT™ brand is now available in Canada, Australia, Germany, Israel, and Switzerland, representing a combined population of approximately 127 million.

How will Avant Brands (AVTBF) generate revenue from this partnership with Nectar?

Avant Brands will receive its standard international sales price for BLK MKT™ products and earn an additional royalty fee on Nectar's net sales of these products in Australia.

AVANT BRANDS INC

OTC:AVTBF

AVTBF Rankings

AVTBF Latest News

AVTBF Stock Data

7.25M
9.14M
14.04%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Kelowna